Keywords
vein of Galen aneurysmal malformation - vein of Galen - review
Introduction
Vein of Galen aneurysmal malformation (VGAM) is a rare congenital intracranial arteriovenous
deformation resulting from an anomalous fistulous connection between the primitive
choroidal vessels and the most proximal part of the median prosencephalic vein of
Markowski (MProsV). The incidence has been reported as 1:25,000.[1] It accounts for 1% of cerebral vascular malformations and 30% of pediatric vascular
malformations.[2] Clinically, VGAM is commonly diagnosed during the neonatal period and early childhood
according to the symptoms of congestive heart failure and intracranial hypertension.
Steinheil first described this abnormal intracranial arteriovenous connection as “varix
aneurysm” in 1895.[3] Since then, there were various terms used to depict this condition, including “vein
of Galen malformation,” “vein of Galen aneurysmal formation,” “arteriovenous aneurysms
of the vein of Galen,” and “aneurysms of the vein of Galen.” However, these medical
terms are misnomers because the malformation is actually caused by MProsV, rather
than the vein of Galen. The true VGAM was reported by Boldrey and Miller in 1949.[4] The term of vein of Galen “aneurysms” was first proposed by Jaeger et al in 1937.[5] In current understanding, the word, “aneurysms,” is also an description error. This
tendency is arbitrary since the word is derived from the Greek aneurynein, that is, to dilate. Therefore, the use of a “venous aneurysms” is etymologically
legitimate rather than a misnomer.[6]
Endovascular embolization is generally considered to be the first-line therapeutic
option. A meta-analysis performed by Yan et al[7] revealed that the mortality rate of embolized patients decreased from 17 to 12%
from 1980s to 2000s. But the management is still challenging. This article reviewed
the pathogenesis, classification, clinical manifestations, imaging of VGAM, and summarized
the key points of endovascular embolization to improve the rate of treatment and prognosis
for VGAM.
Pathogenesis
The persistent arteriovenous shunting from primitive choroidal vessels into the MProsV
is the predominant pathogenesis of VGAM, which occurs at the 6th to 11th week of gestation,
after development of the circle of Willis ([Fig. 1]). The posterior part of the MProsV persists as the vein of Galen, while the anterior
portion regresses in parallel with the formation of the internal cerebral veins. The
remnants of the MProsV then join the internal cerebral veins to form the vein of Galen,
which may cause the existence of connection between the VGAM and the deep venous system.
Raybaud and Strother[8] identified the dilated venous structure as the MProsV at first. The arteriovenous
connection between primitive choroidal vessels and MProsV leads to hemodynamic abnormalities,
which results in the obstruction of embryologic vein regression and the development
of vein of Galen. Subsequently, the high-output arteriovenous connection contributes
to venous hypertension and aneurysmal dilation of MProsV. Besides, stenosis of dural
sinuses is another cause of the dilatation, resulting from the rapid and turbulent
flow caused by the arteriovenous connection.
Fig. 1 The formation of VGAM.[25] (A) Normal vessel structure between the pericallosal arteries and the PCA is present
in embryonic period. (B) The abnormal high-output arteriovenous connection contributes to aneurysmal dilation
of the MProsV, which leads to the formation of VGAM. This connection drains into the
SS and subsequently into T. In addition, it also bloods into the FS and then into
the AT when the SS is absent, hypogenetic, or stenotic. Reproduced with permission
from Mortazavi et al.[25] AT, accessory torcula; FS, falcine sinus; MProsV, median prosencephalic vein; MRI,
magnetic resonance imaging; PCA, posterior cerebral arteries; SS, straight sinus;
T, trocula; VGAM, vein of Galen aneurysmal malformation.
The drainage of the malformation is toward the straight sinus, and it also drains
into sagittal sinus through the persistent falcine sinus, in this case the straight
sinus is absent, hypogenetic or stenotic.[9] The cases of VGAM with persistent falcine sinus have been reported previously by
us[10] ([Fig. 2]). The arteriovenous deformation is supplied by a variety of arterial feeding vessels
including subependymal network originating from the posterior circle of Willis, thalamoperforating
arteries, choroidal arteries, and the limbic arterial arch.[4] It is located in the cistern of velum interpositum as well as the quadrigeminal
cistern, and there is no connection between the malformation and the deep venous system,
which has been considered traditionally. However, this theory has been challenged
in recent literature reports.[11]
[12]
[13] In these studies, the drainage of the malformation into the deep venous system has
been confirmed by follow-up imaging, including internal cerebral veins, straight sinus,
falcine sinus, basal vein of Rosenthal, and inferior sagittal sinus.
Fig. 2 Cranial sagittal MRI in a patient with VGAM reveals a dilated MProsV (short arrow)
connected with a persistent falcine sinus (long arrow) blooded into the sagittal sinus
and the absence of straight sinus on T1WI (A) and T2WI (B). MProsV, median prosencephalic vein; MRI, magnetic resonance imaging; VGAM, vein
of Galen aneurysmal malformation; WI, weighted imaging.
The genetic susceptibility to VGAM is still unclear, while there are some potentially
causative genes reported in association with this condition. Revencu et al[14] identified RASA1 gene mutation in two patients with VGAM. Chida et al[15] reported one variant of ACVRL1 in a case with VGAM. Tsutsumi et al[16] published a patient with VGAM carrying a mutation in the ENG gene encoding endoglin; this patient presented with a family history of hereditary
hemorrhagic telangiectasia and the authors hypothesized the gene might be etiologically
related to VGAM. Additionally, Xu et al[17] reported a familial VGAM in an adult female patient with VGAM, who had a history
of a stillbirth pregnancy caused by VGAM. However, the relationship between genetic
factors and VGAM needs to be further investigated.
Classification
Vein of Galen Aneurysmal Malformation
The first classification of VGAM was proposed by Litvak et al[18] in 1960. There are two most widely accepted classifications described by Lasjaunias
and Yasargil, respectively ([Table 1]). Based on the age at presentation and angioarchitecture of the fistulae, Lasjaunias
et al[19] divided VGAM into two types: choroidal type and mural type ([Fig. 3]).[20] The choroidal type is the most common type accounting for 56 to 76% of all VGAMs
and is common in males.[21] It mainly occurs in neonates,[22] characterized by congestive heart failure due to a high flow fistula. In choroidal
type, multiple arterial feeders like a nidus shunt into the anterior aspect of MProsV.
The feeder vessels mostly come from the choroidal arteries, involving the anterior
and posterior choroidal, anterior cerebral, as well as quadrigeminal and thalamoperforating
arteries occasionally.[23] In mural type, one or more arteriovenous fistulae (AVF) shunt into the inferolateral
margin in the wall of MProsV with lower flow. The arterial feeders arise from unilateral
or bilateral quadrigeminal arteries and posterior choroidal arteries. Clinically,
it is common in infants and children associated with the symptoms of macrocephaly,
hydrocephalus, and developmental delay. Due to slow flow and few fistulae, it has
a better prognosis, and thrombosis is more common in this type compared with choroidal
type.
Fig. 3 (A) Mural type of VGAM. MR angiography displays an AVF directly into the wall of the
venous pouch. Note the drainage of the malformation into the stenosis straight sinus;
(B) Choroidal type of VGAM. In comparison with mural type, MR angiography of choroidal
type shows an extensive arterial network like a nidus centered in the region of the
quadrigeminal plate cistern (closed arrow), flowing into the malformation and primitive
falcine sinus (open arrow).[20] Reproduced with permission from Triffo et al.[20] AVF, arteriovenous fistula; MR, magnetic resonance; VGAM, vein of Galen aneurysmal
malformation.
Table 1
Classification of VGAM
|
Lasjaunias' classification
|
Yasargil's classification
|
|
Mural type
|
Type I
|
|
Choroidal type
|
Type II
|
|
Type III
|
|
Type IV (type IVA, type IVB, type IVC)
|
Abbreviation: VGAM, vein of Galen aneurysmal malformation.
Yasargil[24] dichotomized VGAM into four types according to whether the malformation is a pure
AVF (types I–III) or an arteriovenous malformation (AVM) with or without associated
AVF (types IVA–C), and the exact origin of the feeding arteries. Type I is a pure
AVF between posterior cerebral artery (P4 and its branches), anterior or posterior
pericallosal arteries, and the vein of Galen. Type II is the fistulous connection
between the thalamoperforators (basilar and P1 segment) and the vein of Galen. Type
III is a mixture of type I and II, which is the commonest type. Type IV comprises
three subtypes. Type IVA is similar to type IVB. Both types IVA and IVB are aneurysmal
dilation of the vein of Galen caused by shunting from an adjacent thalamic and mesencephalic
AVM, respectively. Type IVC is a thalamomesencephalic or mesodiencephalic plexiform
malformation along with an adjacent and separate cisternal AVF to the vein of Galen.[25]
[26] Though the Yasargil's classification is classic and widely recognized, there are
several deficiencies. The clinical presentation and outcome are not involved in the
Yasargil's classification.
Vein of Galen Aneurysmal Dilatation
Vein of Galen aneurysmal dilatation (VGAD) refers to the dilated vein of Galen arising
from the drainage of an AVM into the true vein of Galen rather than the precursor
of the vein of Galen. It belongs to the group of dura AVM. Different from VGAM, it
is a real malformation of Galen vein and contacted with the deep venous system. The
arterial supply comprises the internal carotid artery, meningeal branches of internal
and external carotid artery, normal sinus, the drainage from Galen vein into brain
parenchyma, and mesencephalic or diencephalic AVM.[27] Based on the source of abnormal blood, VGAD can be differentiated into (1) solid
type, (2) varicose type, and (3) dura mater type. According to the shunt location
of VGAD, Iizuka et al[28] proposed a new anatomical classification, involving (1) ventricular type, (2) cisternal
type, and (3) parenchymal type.
Vein of Galen Varices
Vein of Galen varices is the varicose dilatation of the Galen vein without an arteriovenous
shunt. There are two types of the vein of Galen varices in children. The first type
is a transient dilatation of the Galen vein accompanied with heart failure caused
by other origins. This type is asymptomatic and cardiac function is improved along
with the disappearance of the dilatation. The second type occurs when flowing a complete
hemisphere into the deep venous system. It is also asymptomatic, but the venous ischemia
disorders may occur as a result of insufficient venous drainage.[25]
Clinical Manifestations
Clinical presentations vary with the age of onset and vascular architecture. The main
manifestations include congestive heart failure, hydrocephalus, and neurological symptoms.
In 1964, Gold et al[29] proposed a clinical classification based on the age of onset, including the group
of neonates, infants as well as children and adults. In neonates, the predominant
clinical manifestation is represented by serious congestive heart failure. The prognosis
is extremely poor with high mortality, and choroidal type is common in this group.
During infancy, clinical presentations mainly consist of hydrocephalus, macrocephaly,
seizures, developmental delay, and mild heart failure. The mechanisms causing hydrocephalus
include hypertension, impaired cerebrospinal fluid reabsorption, and compression of
mesencephalic aqueduct. Mural type usually occurs in this group. In children and young
adults, the symptoms consist of headache, hydrocephalus, seizure, neural dysfunction,
and subarachnoid hemorrhage. Both choroidal and mural types are observed in this group.
In addition, there are some rare clinical manifestations reported in the literature,
which include galactosemia,[30] abnormal movement (e.g., chronic asymmetric tremor),[31] a pulsatile right-sided neck swelling due to tortuous carotid artery and bilateral
dilatation of neck veins,[32] jugular bulb stenosis,[33] dilated scalp veins, and tonsillar prolapse. But the relationship between these
clinical manifestation and VGAM needs to be further confirmed.
Additionally, Lasjaunias et al[22] recommended the Bicêtre neonatal evaluation score system, which takes into account
neurological, cardiac, respiratory, renal, and hepatic functions ([Table 2]). It helps to estimate the comprehensive symptoms of patients with VGAM and assists
with the therapeutic decision. A score of less than 8 indicates a poor outcome needing
expectant treatment. An emergency endovascular treatment is advised relating to a
score of 8 to 12. The embolization can be delayed until 5 months of age associated
with a score of 13 to 21. Besides, the evaluation of the neurocognitive status could
be performed using the Denver test and the Brunet-Lézine test.[34]
Table 2
Bicêtre neonatal evaluation score[22]
|
Points
|
Cardiac function
|
Cerebral function
|
Respiratory function
|
Hepatic function
|
Renal function
|
|
5
|
Normal
|
Normal
|
Normal
|
—
|
—
|
|
4
|
Overload, no medical treatment
|
Subclinical, isolated EEG abnormalities
|
Tachypnea, finishes bottle
|
—
|
—
|
|
3
|
failure, stable with medical treatment
|
Nonconvulsive intermittent neurological signs
|
Tachypnea, does not finish bottle
|
No hepatomegaly, normal hepatic function
|
Normal
|
|
2
|
Failure, not stable with medical treatment
|
Isolated convulsion
|
Assisted ventilation, normal saturation FIO2 < 25%
|
Hepatomegaly, normal hepatic function
|
Transient anuria
|
|
1
|
Ventilation necessary
|
Seizures
|
Assisted ventilation, normal saturation FIO2 > 25%
|
Moderate or transient hepatic insufficiency
|
Unstable diuresis with treatment
|
|
0
|
Resistant to medical therapy
|
Permanent neurological signs
|
Assisted ventilation, desaturation
|
Abnormal coagulation, elevated enzymes
|
Anuria
|
Abbreviations: EEG, electroencephalogram; FIO2, fractional inspired oxygen.
Maximal score = 5 (cardiac) + 5 (cerebral) + 5 (respiratory) + 3 (hepatic) + 3 (renal) = 21.
Source: Reproduced with permission from Lasjaunias et al.[22]
Imaging
VGAM is one of the diseases mostly diagnosed prenatally with the proportion of approximately
40%.[35] However, a retrospective analysis of 25 patients with VGAM conducted by Geibprasert
et al[36] showed there was no relevance between early prenatal diagnosis and the follow-up
outcome. But it assisted in the decision of therapy plan and facilities. Prenatal
diagnosis is usually made during the third trimester of pregnancy by ultrasonography
according to the visualization of an anechogenic or hypoechogenic round or ovoid structure
with regular borders located in the midline of the posterior part of the third ventricle.
Enough dilatation of the malformation is required if it can be detected on the first-
or even second-trimester ultrasound[36] and the conformation of the antenatal diagnosis is usually performed by color Doppler
imaging and magnetic resonance imaging (MRI). There is an antenatal VGAM classification
including isolated VGAM, when VGAM is the only manifestation and associated VGAM,
when VGAM is associated with cardiac and neurological abnormalities.[37] However, it might be challenged in the future research. Termination of pregnancy
should be performed when fetal hydrops and serious heart failure occur.
The chest radiograph shows cardiomegaly resulting from congestive heart failure. Brain
radiograph may display a rim of calcification within the wall of the aneurysmal sac,
which is considered to be a poor indicator associated with the tendency of subsequent
thrombosis.[25] Cranial computed tomography (CT) usually displays a spherical mass located in the
quadrigeminal cistern or the cistern of velum interpositum. Dilated ventricular system,
periventricular white matter hypodensities, and diffuse cerebral atrophy are usually
associated MRI findings ([Fig. 4]). MRI has the advantage to accurately demonstrate the location of the lesion, vascular
architecture, and status of vessel drainage in the VGAM malformation ([Fig. 5]); furthermore, the position and identity of major arterial trunks, primary branches
as well as secondary branches feeding the fistula are better recognized on brain MRI
than on cranial CT.[38] Additionally, parenchymal changes including focal encephalomalacia and diffuse brain
volume loss can also be visible in CT and MRI, which are considered to be predictors
of poor outcome.[36] Angiography (including MR angiography and CT angiography) remains the gold standard
for the diagnosis. It has advantages in revealing the site, size, morphology, and
abnormal flow dynamics of vessels ([Fig. 6]). Similarly, it better shows the small feeders supplying the fistula, as well as
the dynamic aspects of the venous drainage into the normal brain and hemodynamics
of the arteriovenous shunt.[26]
[35] Strategies for the decision of treatment can be made according to the evidence on
angiography. In future applications, four-dimensional flow MRI is probably useful
in the management and monitoring intracranial hemodynamic alteration during embolizations,
to estimate the efficacy and risk of reperfusion complications.[39] Wu et al[40] indicated that it assisted in detecting the arteriovenous shunt flow, cerebral vessel
inflow, and cerebral flow redistribution after embolizations during staged embolizations
of six patients with VGAM.
Fig. 4 Axial CT scan of brain in a patient with VGAM reveals a large homogeneous, well-defined
spherical mass associated with dilated third and lateral ventricles and hydrocephalus
because of the compression of the aqueduct, as well as periventricular white matter
hypodensities (arrows). CT, computed tomography; VGAM, vein of Galen aneurysmal malformation.
Fig. 5 Cerebral MRI in axial of a patient with VGAM shows a well-defined midline round mass
within the pineal region accompanied with the dilatation of lateral and third ventricles
on T1WI (A) and T2WI (B). MRI, magnetic resonance imaging; VGAM, vein of Galen aneurysmal malformation; WI,
weighted imaging.
Fig. 6 (A) MR angiography shows the dilated aneurysmal mass with some feeding vessels which
drains into the straight sinus. (B) Vertebral artery angiography displays the dilated median prosencephalic vein blooding
into the straight sinus, which belongs to the mural type of VGAM. (C) Lateral view reveals the stenosis of straight sinus (arrow) draining directly into
the superior sagittal sinus. MR, magnetic resonance; VGAM, vein of Galen aneurysmal
malformation.
The spontaneous thrombosis of VGAM is rare and the underlying causal mechanism is
not entirely understood. There are multifactors described including the alteration
of hemodynamics (slow flow, increased pressure, or turbulence), vascular spasm, vascular
proliferation, and regressive atherosclerotic changes in the vessels.[41]
[42] The ventricular shunting and the use of contrast media for angiography are also
considered to be correlated with the thrombosis of VGAM.[41] The imaging investigation can well demonstrate the features of thrombosis. On CT,
it reveals heterogeneous signal associated with calcified capsule occasionally. Contrast-enhanced
CT shows a central thrombus and peripheral circulating blood along the wall of the
sac, called “target-sign.”[26] MRI of the thrombosis VGAM displays extracellular methemoglobin in the central part
and hemosiderin in the peripheral part of lesion.[43]
Management
The purpose of therapy is various according to the age of onset. In newborns, the
goal of therapy is mainly the correction of heart failure, while in older children
the aim is to improve the neurological symptoms.[4] It is advised that the therapy outcome is to reverse the pathophysiologic effects
caused by the arteriovenous deformation rather than to obtain a complete normal morphologic
appearance.[44] The management of VGAM includes a combination of surgical approaches, endovascular
treatments, radiosurgery, and conservative treatments. Endovascular embolization is
the preferred treatment and others are considered to be the complementary options,
when embolization is limited.
Surgery and Radiosurgery
Though the method of surgery is widely used, the complete resection and surgical clipping
of the vessels are still challenging with higher morbidity and mortality. The problem
is associated with surgery including the deep location of the lesion, high-flow shunt,
complex vascular architecture, and poor tolerance in infants. Therefore, surgery is
usually considered as a complementary approach when embolization is failed. Additionally,
ventricular shunting may exacerbate the cerebral venous hypertension and brain ischemia
due to the alteration of venous drainage. Hence, ventricular shunting should be performed
after embolization.[22]
[26] Similarly, the approach of Gamma knife surgery is also a complementary alternative
since it does not reduce the size of the lesion immediately. Stereotactic radiotherapy
may have an effect on some patients with VGAM, but its effect is still not clear.
Besides, there is controversy about the lesion to the development of brain.
Endovascular Therapy
The first case treated by embolization was reported in 1950 by Davis.[45] With the development of endovascular treatment, the mortality rate has dropped from
60–82% to 11%.[46] The goal of endovascular therapy is to reduce intracranial shunting or even occlude
all the fistulae ([Fig. 7]). In fact, total obliteration is not necessary because a reduction in one-third
to half of the shunt is enough to correct the clinical symptoms.[47] Recently, a meta-analysis showed the predominant complications of endovascular treatment
consisted of cerebral vessel perforation, hemorrhage, cerebral ischemia, hydrocephalus,
and leg ischemia.[7] The prevention of complications depends on proper super selective embolization,
selection of embolic material and exact technique, as well as preservation of normal
cerebral deep venous drainage. Additionally, the existence of normal drainage between
deep venous system and VGAM should be considered before embolization in case of the
occurrence of adverse effects to the normal cerebral vessel after endovascular management.
Although it is difficult to be seen through angiograms or noninvasive imaging presumably
due to technical factors and hemodynamics, the drainage is a critical element of the
treatment planning.[11]
Fig. 7 Carotid angiogram of a patient with VGAM displays a dilated aneurysmal malformation
(A). Post-embolization angiogram shows the complete occlusion of the malformation using
Guglielmi coils in anteroposterior (B) and lateral (C) views. VGAM, vein of Galen aneurysmal malformation.
There are two options of embolization including transarterial and transvenous approach,
of which the transarterial route is preferred. Umbilical artery approach can be used
for embolization in the early neonatal period, and the femoral artery is an alternative
route when the umbilical artery is not available. As for transvenous approach, there
is a controversy regarding the outcome of transvenous embolization. In previous literature,
it was considered to be not feasible due to increased morbidity. In recent article,
Orlov et al[48] considered it was a safe and effective salvage method for VGAM with restricted transarterial
access. Besides, Meila et al[49] described a combined transvenous and transarterial approach, called kissing microcatheter
technique. It was considered to be a safe method with lower complication rate and
the overall outcome can be improved, particularly in the neonate with congestive heart
failure. The embolic agents comprise coils, microballoons, N-butyl-cyanoacrylate (NBCA), Onyx liquid, and ethylene vinyl alcohol copolymer. In
choroidal type of VGAM, Onyx is recommended because of the advantage of more definitive
and stable occlusion. In mural type, NBCA is a preferred embolic material due to the
properties of quick precipitation and adhesion to vessel.[48] In addition, Joo et al[42] first reported a patient with a mural-type VGAM who was successfully treated using
the Micro Vascular Plug system, which may be a potential available option.
The staged embolization is recommended to minimize the occurrence of complications
such as a normal perfusion pressure breakthrough phenomenon or a multiple venous thrombosis.[11] The interval is usually 3 to 6 months.[4]
[23] There is a new classification scoring system for the decision of treatment proposed
by Mortazavi et al,[25] which combines arterial feeders with clinical symptoms and age ([Table 3]). Embolization is not urgent and one stage of embolization is suggested for patients
with a score of 0 to 1. Urgent embolization and multiple stages of treatment are recommended
when the score is 2 points. Embolization in multiple stages or palliative treatment
is advised for patients with a score of 3.
Table 3
New classification system proposed by Mortazavi et al[25]
|
Score
|
|
Parameter
|
0
|
1
|
|
Arterial feeders
|
Any feeders other than P1–2, thalamoperforators, choroidal, basilar
|
Any of the following feeders: P1–2, thalamoperforators, choroidal, basilar
|
|
Clinical symptoms
|
No heart failure
|
Heart failure
|
|
Age
|
≥ 5 months
|
< 5 months
|
Source: Reproduced with permission from Mortazavi et al.[25]
The time of endovascular management depends on the clinical symptom and is preferably
at the age of 5 to 6 months for maximum safety and efficacy of treatment.[26] However, symptoms related to the possible progression of the heart failure and the
potential development of hydrocephalus need to be closely followed up[50]
. The decision of management can be evaluated by the Bicêtre scoring system proposed
by Alvarez et al[4] ([Table 2]). A score of more than 12 suggests the clinical symptom is stable and it is better
to prolong therapy until the age of 5 to 6 months. Endovascular embolization is recommended
when a score is between 8 and 12. There is no indication for embolization associated
with a score of less than 8.
VGAD is the pathological dilatation of Galen vein due to the stenosis or obstruction
of the outflow. The degree of dilatation is varied with the extent of stenosis. So,
the treatment of VGAD with high flow is mainly planned embolization or stereotactic
radiotherapy. For low level VGAD, intravascular embolization is the major approach
of management.[27] It is associated with a good prognosis in comparison with VGAM because VGAM has
high morbidity and mortality due to refractory high-output heart failure and neurological
damage.[51] As for the vein of Galen varices, it has lower hemorrhage risk and better outcome.
The adverse consequence may occur as a result of an inappropriate surgical or interventional
management. Conservative treatment is recommended for patients with stable symptoms,[52] and close follow-up with imaging investigations is essential.
Prognosis
Without treatment, more than 90% of patients with VGAM die in the neonatal and infant
period. A meta-analysis about the outcome and complications of endovascular embolization
for VGAM revealed the proportion of the good outcome increased from 49 to 70% from
1980s to 2000s.[7] But the morbidity and mortality are still very high. There are some factors that
correlated with the clinical outcome involving embolization technology, clinical presentation
(multiorgan failure and neurological symptoms), and imaging findings (extensive encephalomalacia,
arterial steal, parenchymal calcification, and high-flow multifeeder shunts).[36] Additionally, the choroidal type of VGAM has worse prognosis than mural type. Agarwal
et al[53] retrospectively analyzed 36 patients with VGAM and concluded that jugular atresia
was significantly associated with poor outcome. A systematic review conducted by Yan
et al[54] showed the outcome was good in the patient with an early spontaneous thrombosis,
while the outcome was poor in the late stages of the VGAM with spontaneous thrombosis.
The main sequela of VGAM is represented by permanent neurological deficit with intellectual
disability and epilepsy. The evaluation of therapy outcome in patients with VGAM can
be performed by the system of Bicêtre admission and outcome score proposed by Lasjaunias
et al[22] ([Table 4]). This scoring system can help to estimate the effect of clinical treatment, contribute
to correct the therapy approaches, and improve the level of management of VGAM.
Table 4
Bicetre admission and outcome score[22]
|
Score
|
Condition
|
|
5
|
Normal (N)
|
|
4
|
Minimal non-neurological symptoms, not treated (MS), and/or asymptomatic enlargement
of the cardiac silhouette
|
|
3
|
Transient neurological symptoms, not treated (TNS), and/or asymptomatic cardiac overload
under treatment
|
|
2
|
Permanent minor neurological symptoms, mental retardation of up to 20%, nonpermanent
neurological symptoms under treatment (MNS), normal school with support, and/or cardiac
failure stabilized with treatment
|
|
1
|
Severe neurological symptoms, mental retardation of more than 20% (SNS), specialized
school and/or cardiac failure unstable despite treatment
|
|
0
|
Death(D)
|
Note: Does not apply to neonates.
Source: Reproduced with permission from Lasjaunias et al.[22]
In this study, we performed a literature retrospective of relevant articles in the
recent 15 years using the database of PubMed (https://www.ncbi.nlm.nih.gov/pubmed) with the key words “vein of Galen aneurysmal malformation” or “VGAM.” The detail
information was collected, including age, sex, types of VGAM, clinical feature, treatment,
and outcome ([Tables 5] and [6]). A total of 43 patients (36 children and 7 adults) were enrolled. We found that
the mortality of VGAM was still high. The prognosis of VGAM in adult was better than
children, and the mural type was associated with a good outcome compared with choroid
type.
Table 5
Literature review of clinical outcomes after treatment of VGAM in children
|
Authors
|
Age/sex
|
Type
|
Clinical features
|
Treatment
|
Outcome
|
|
Pop et al[55]
|
11 mo/M
|
Mural
|
IHC, DD
|
Femoral TA
Embolization
|
Normal
|
|
Gupta et al[26]
|
1y/M
|
Mural
|
MC, ASD occipital bruit
|
Embolization (TA)
|
Normal
|
|
Triffo et al[20]
|
Neonate/M
|
Mural
|
PD, CHF, RD
|
Embolization (TA), GKRS
|
Normal
|
|
Jones et al[56]
|
Neonate/F
|
Mural
|
PD, Mild CHF
|
Embolization (TA)
|
Normal
|
|
Ellis et al[57]
|
5 mo/M
|
Mural
|
MC, cranial bruit
|
Embolization
|
Normal
|
|
Ellis et al[57]
|
Neonate/F
|
Mural
|
PD, CHF
|
Embolization
|
Normal
|
|
Joo et al[42]
|
4 mo/F
|
Mural
|
IHC, DFV, NSC, lethargy
|
Embolization (TA)
|
Normal
|
|
Gupta et al[26]
|
3 y/M
|
Mural
|
H
|
Embolization (TV and TA)
|
Died
|
|
Filippi et al[30]
|
Neonate/M
|
Mural
|
PD, H, CD, HF, HM
|
Embolization (TA)
|
Died
|
|
Orlov et al[48]
|
Neonate/M
|
Mural
|
PD, CHF
|
Embolization (TA)
|
Sz, mild DD
|
|
Ellis et al[57]
|
21 mo/F
|
Mural
|
MC, cranial bruit
|
Embolization
|
LSH, ANP, DVA
|
|
Heuer et al[50]
|
Neonate/M
|
Mural
|
RVH, RVD
|
None
|
Improved
|
|
Cai et al[58]
|
15 mo/M
|
Mural
|
Sz, DFV, IHC
|
Embolization (TV)
|
Improved
|
|
Kong we al[59]
|
Neonate/M
|
Mural
|
PD, H, IVH, V
|
Embolization (TA)
|
Improved
|
|
Orlov et al[48]
|
Neonate/M
|
Choroidal
|
PD, no symptom
|
Embolization (TA)
|
Normal
|
|
Tsutsumi et al[16]
|
Neonate/M
|
Choroidal
|
CD, HM, HF, cardiac bruit,
|
Embolization (TA)
|
Normal
|
|
Ellis et al[57]
|
Neonate/M
|
Choroidal
|
CHF, cranial bruit
|
Embolization
|
Normal
|
|
Heuer et al[50]
|
5 d/M
|
Choroidal
|
HF
|
Embolization
|
Normal
|
|
Heuer et al[50]
|
7 d/F
|
Choroidal
|
HF
|
Embolization
|
Normal
|
|
Heuer et al[50]
|
31 mo/M
|
Choroidal
|
Mild LVH hemorrhage
|
Embolization
|
Normal
|
|
Heuer et al[50]
|
6 mo/M
|
Choroidal
|
None
|
Embolization
|
Normal
|
|
Heuer et al[50]
|
Neonate/M
|
Choroidal
|
Mild HF
|
Embolization
|
Normal
|
|
Heuer et al[50]
|
Neonate/F
|
Choroidal
|
HF
|
Embolization
|
Died
|
|
Heuer et al[50]
|
6 d/M
|
Choroidal
|
HF, RVH, RVD
|
Embolization
|
Died
|
|
Heuer et al[50]
|
Neonate/M
|
Choroidal
|
HF, PDA, Sz, ischemia
|
Embolization
|
Died
|
|
Jones et al[56]
|
Neonate/M
|
Choroidal
|
PD, CHF, ASD
|
Embolization (TA)
|
Died
|
|
Komiyama et al[60]
|
Neonate/M
|
Choroidal
|
CHF
|
Femoral TA
Embolization
|
Died
|
|
Orlov et al[48]
|
Neonate/M
|
Choroidal
|
H
|
Embolization (TA)
|
Mild DD
|
|
Heuer et al[50]
|
Neonate/M
|
Choroidal
|
RVD, PFO, Sz, ischemia,
|
Embolization
|
Severe MR
|
|
Heuer et al[50]
|
Neonate/F
|
Choroidal
|
HF, Sz, ischemia,
|
Embolization
|
Hemiparesis, mild MR
|
|
Heuer et al[50]
|
14 mo/M
|
Choroidal
|
Sz, ischemia
|
Embolization
|
Hemiparesis, autistic, epilepsy in remission
|
|
Heuer et al[50]
|
45 d/M
|
Choroidal
|
PFO, hemorrhage
|
Embolization
|
H, mild motor delay
|
|
Demartini et al[47]
|
Neonate/M
|
Choroidal
|
HF, PC, DD, V
|
Embolization (TA and TV)
|
Improved
|
|
Fourie et al[61]
|
Neonate/M
|
Choroidal
|
PC, CHF, cerebral bruit
|
Embolization (TA and TV)
|
Improved
|
|
Jagadeesan et al[62]
|
Neonate/M
|
Mixed type
|
ASD, PFO
|
Embolization (TV and TA)
|
Dysconjugate gaze
|
|
Levrier et al[13]
|
11 y/F
|
Mixed type
|
MC, MR, H
|
Embolization (TV and TA)
|
Improved
|
Abbreviations: ANP, abducens nerve palsy; ASD, atrial septal defect; CD, cardiomegaly;
CHF, congestive heart failure; DFV, dilate scalp and facial veins; DVA, decreased
visual acuity; F, female; GKRS, Gamma Knife radiosurgery; H, hydrocephalus; HF, heart
failure; HM, hepatomegaly; IHC, increasing head circumference; IVH, intraventricular
hemorrhage; LSH, left sided hemiparesis; LVH, left ventricular hypertrophy; M, male;
MC, macrocrania; MR, mental retardation; NSC, nasal and sinus congestion; PC, perioral
cyanosis; DD, delay development; PD, prenatal diagnosis; PDA, patent ductus arteriosus;
PFO, patent foramen ovale; RD, respiratory distress; RVD, right ventricular dilation;
RVH, right ventricular hypertrophy; Sz, seizure; TA, transarterial; TV, transvenous;
V, vomiting; VAGM, vein of Galen aneurysmal malformation.
Table 6
Literature review of clinical outcomes after treatment of VGAM in adult
|
Authors
|
Age/sex
|
Type
|
Clinical features
|
Treatment
|
Outcome
|
|
Gupta et al[26]
|
21 y/F
|
Mural
|
H, SAH, neck stiffness
|
Embolization (TA)
|
Normal
|
|
Levrier et al[13]
|
40 y/M
|
Mural
|
Pituitary dysfunction
|
Femoral TA
Embolization
|
Normal
|
|
Ellis et al[57]
|
24 y/M
|
Mural
|
Face pain, dementia
|
Embolization
|
Normal
|
|
Xu et al[17]
|
44 y/F
|
Choroidal
|
Dizziness, vertigo
|
None
|
Normal
|
|
Gupta et al[26]
|
28 y/M
|
Choroidal
|
HA, IVH
|
Embolization (TV and TA)
|
Died
|
|
Porzionato et al[63]
|
36 y/M
|
Choroidal
|
IVH, coma
|
VS
|
Died
|
|
Triffo et al[20]
|
27 y/M
|
Choroidal
|
RTH, VM
|
GKRS
|
DFNT
|
Abbreviations: DFNT, dysmetria on finger-to-nose test; F, female; GKRS, Gamma Knife
radiosurgery; H, hydrocephalus; HA, headache; IVH, intraventricular hemorrhage; M,
male; RTH, right thalamic hemorrhage; SAH, subarachnoid hemorrhage; TA, transarterial;
TV, transvenous; VAGM, vein of Galen aneurysmal malformation; VM, ventriculomegaly;
VS, ventricle-peritoneal shunt.
Conclusion
VGAM is a rare congenital intracranial arteriovenous deformation associated with high
mortality. To increase and ameliorate the VGAM diagnosis and therapy, it is crucial
to fully understand the pathogenesis, clinical classification, and features of this
condition. Imaging plays an important role in the visualization of vascular architecture
and also in assisting the treatment with embolization procedures. The evaluation of
the time and stages for endovascular treatment based on the score systems will be
beneficial to decrease the complication rate, morbidity, and mortality.